Literature DB >> 30784207

Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc<sup/>.

Motohiro Okada1, Kouji Fukuyama1, Yasuhiro Kawano1, Takashi Shiroyama1, Yuto Ueda1.   

Abstract

Deficiencies in N-methyl-d-aspartate (NMDA)/glutamate receptor (NMDAR) signaling have been considered central to the cognitive impairments of schizophrenia; however, an NMDAR antagonist memantine (MEM) improves cognitive impairments of Alzheimer's disease and schizophrenia. These mechanisms of paradoxical clinical effects of NMDAR antagonists remain unclear. To explore the mechanisms by which MK801 and MEM affect thalamocortical transmission, we determined interactions between local administrations of MK801, MEM, system xc- (Sxc), and metabotropic glutamate receptors (mGluRs) on extracellular glutamate and GABA levels in the mediodorsal thalamic nucleus (MDTN) and medial prefrontal cortex (mPFC) using dual-probe microdialysis with ultra-high-pressure liquid chromatography. Effects of MK801 and MEM on Sxc activity were also determined using primary cultured astrocytes. Sxc activity was enhanced by MEM, but was unaffected by MK801. MK801 enhanced thalamocortical glutamatergic transmission by GABAergic disinhibition in the MDTN. In the MDTN and the mPFC, MEM weakly increased glutamate release by activating Sxc, whereas MEM inhibited thalamocortical glutamatergic transmission. Paradoxical effects of MEM were induced following secondary activation of inhibitory II-mGluR and III-mGluR by exporting glutamate from astroglial Sxc. The present results suggest that the effects of therapeutically relevant concentrations of MEM on thalamocortical glutamatergic transmission are predominantly caused by activation of Sxc rather than inhibition of NMDAR. These demonstrations suggest that the combination between reduced NMDAR and activated Sxc contribute to the neuroprotective effects of MEM. Furthermore, activation of Sxc may compensate for the cognitive impairments that are induced by hyperactivation of thalamocortical glutamatergic transmission following activation of Sxc/II-mGluR in the MDTN and Sxc/II-mGluR/III-mGluR in the mPFC.
© 2019 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Keywords:  cystine/glutamate antiporter; mediodorsal thalamic nucleus; memantine; schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 30784207     DOI: 10.1002/prp2.457

Source DB:  PubMed          Journal:  Pharmacol Res Perspect        ISSN: 2052-1707


  11 in total

1.  Neurogenesis and Neuroplasticity in Major Depression: Its Therapeutic Implication.

Authors:  Michel Bourin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The effect of NMDA-R antagonist, MK-801, on neuronal mismatch along the rat auditory thalamocortical pathway.

Authors:  Gloria G Parras; Catalina Valdés-Baizabal; Lauren Harms; Patricia T Michie; Manuel S Malmierca
Journal:  Sci Rep       Date:  2020-07-24       Impact factor: 4.379

3.  Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus.

Authors:  Motohiro Okada; Kouji Fukuyama
Journal:  Biomolecules       Date:  2020-07-01

4.  Amantadine Combines Astroglial System Xc- Activation with Glutamate/NMDA Receptor Inhibition.

Authors:  Tomosuke Nakano; Toshiki Hasegawa; Dai Suzuki; Eishi Motomura; Motohiro Okada
Journal:  Biomolecules       Date:  2019-05-17

5.  Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc<sup/>.

Authors:  Motohiro Okada; Kouji Fukuyama; Yasuhiro Kawano; Takashi Shiroyama; Yuto Ueda
Journal:  Pharmacol Res Perspect       Date:  2019-01-07

6.  Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor.

Authors:  Kouji Fukuyama; Ryo Kato; Masahiko Murata; Takashi Shiroyama; Motohiro Okada
Journal:  Biomolecules       Date:  2019-06-17

7.  Amantadine Improves Delayed Neuropsychiatric Sequelae of Carbon Monoxide Poisoning: A Case Report.

Authors:  Tomosuke Nakano; Toshiki Hasegawa; Dai Suzuki; Eishi Motomura; Motohiro Okada
Journal:  Brain Sci       Date:  2019-10-25

8.  Relationships between Expenditure of Regional Governments and Suicide Mortalities Caused by Six Major Motives in Japan.

Authors:  Toshiki Hasegawa; Kouji Fukuyama; Motohiro Okada
Journal:  Int J Environ Res Public Health       Date:  2021-12-22       Impact factor: 3.390

9.  Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43.

Authors:  Kouji Fukuyama; Motohiro Okada
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 10.  A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43.

Authors:  Motohiro Okada; Kouji Fukuyama; Takashi Shiroyama; Masahiko Murata
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.